Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients

NCT01718613 is registered in ClinicalTrials.gov with Instituto do Cancer do Estado de São Paulo as lead sponsor.

NCT NCT01718613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01718613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients
Lead sponsor
Instituto do Cancer do Estado de São Paulo
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2012
Completion date
May 31, 2018
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock